gefitinib has been researched along with fucoxanthin in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (fucoxanthin) | Trials (fucoxanthin) | Recent Studies (post-2010) (fucoxanthin) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 538 | 4 | 438 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chang Zhou, S; Chen, H; Huang, Y; Li, YY; Liu, H; Ming, JX; Ohishi, H; Qin, MY; Shao, Y; Wang, H; Wang, ZC; Wu, RJ; Wu, ZL; Xu, R | 1 |
1 other study(ies) available for gefitinib and fucoxanthin
Article | Year |
---|---|
Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gefitinib; Gene Knockdown Techniques; Humans; Laminaria; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Tissue Inhibitor of Metalloproteinase-2; Xanthophylls; Xenograft Model Antitumor Assays | 2021 |